The NeurologyLive® Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.
Challenges and Solutions in the Management of Multiple Sclerosis
November 22nd 2022A panel of experts in neurology discuss comorbidities in multiple sclerosis and the use of sphingosine 1-phosphate receptor modulators for treatment. They discuss data on sequencing of disease modifying therapies and challenges and their approaches to guiding patients through treatment discontinuations.
Neuromyelitis Optica Spectrum Disorder (NMOSD) Care in Diverse Patient Populations
September 2nd 2022Experts in neurology provide insight on neuromyelitis optica spectrum disorder (NMOSD) in racially and ethnically diverse patient populations, highlighting treatment considerations and engaging patients in clinical trial and therapeutic development.
Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus
March 18th 2022In this Peer Exchange special edition, Scott Newsome, DO, leads a discussion with Alberto Ascherio, MD, DrPH; Anne Cross, MD; Avindra Nath, MD; and Michael Racke, MD, about the practical and clinical implications of a recently published novel longitudinal study, the first of its kind to draw a causal link between Epstein-Barr Virus and multiple sclerosis.
Optimal Management of Acute and Preventive Migraine
January 18th 2022Jessica Ailani, MD; Bradley Torphy, MD; Sait Ashina, MD; Andrew C. Charles, MD; and Julio R. Vieira, MD, share expert approaches to the diagnosis and treatment of acute and preventive migraine and discuss key insights on the evolving treatment landscape.
Optimal Management of Relapsing Multiple Sclerosis
June 29th 2021Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD explore several topics pertaining to the diagnosis and treatment of relapsing multiple sclerosis (MS), including current treatment options, therapy sequencing, and the future of MS management.
The Changing Landscape in the Treatment of Spinal Muscular Atrophy
April 16th 2021Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD provide a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.
Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)
April 13th 2021Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.
Updates in the Management of Relapsing Multiple Sclerosis
December 10th 2020Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.